Morral, Clara
Ayyaz, Arshad
Kuo, Hsuan-Cheng
Fink, Mardi
Verginadis, Ioannis I.
Daniel, Andrea R.
Burner, Danielle N.
Driver, Lucy M. http://orcid.org/0000-0002-8868-3242
Satow, Sloane
Hasapis, Stephanie
Ghinnagow, Reem
Luo, Lixia
Ma, Yan
Attardi, Laura D. http://orcid.org/0000-0003-1782-9045
Koumenis, Constantinos
Minn, Andy J. http://orcid.org/0000-0003-1418-0906
Wrana, Jeffrey L. http://orcid.org/0000-0003-0932-0644
Lee, Chang-Lung http://orcid.org/0000-0002-0673-633X
Kirsch, David G. http://orcid.org/0000-0002-2086-205X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (2U19AI067798, 2U19AI067798, U19AI067773)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1P01CA257904, 2R35CA197616, 1P01CA257904, 1P01CA257904)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
The Mark Foundation for Cancer Research
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Duke University School of Medicine Whitehead Scholar Award
Article History
Received: 3 March 2023
Accepted: 20 March 2024
First Online: 8 April 2024
Change Date: 22 April 2024
Change Type: Update
Change Details: The HTML version of this article contained capitalization errors in figure 3, panels a, b, c and figure 4, panel a, b, in which ‘P53’ was used instead of ‘p53’. In addition, in figure 3, panels c, f, ‘Dapi’ was used instead of ‘DAPI’. The original HTML article of the article has been corrected. The PDF version was unaffected by this error.
Competing interests
: D.G.K. is a co-founder of and stockholder in XRad Therapeutics, which is developing radiosensitizers. D.G.K. is a member of the scientific advisory board and owns stock in Lumicell Inc., a company commercializing intraoperative imaging technology. None of these affiliations represents a conflict of interest with respect to the work described in this manuscript. D.G.K. is a coinventor on a patent for a handheld imaging device and is a coinventor on a patent for radiosensitizers. XRad Therapeutics, Merck, Bristol Myers Squibb, and Varian Medical Systems provided research support to D.G.K., but this did not support the research described in this manuscript. C.-L.L. reports research support from Rythera Therapeutics; however, this does not present a conflict of interest with the content of this manuscript. The remaining authors declare no competing interests.